The RELATION study: efficacy and safety of ranibizumab combined with laser photocoagulation treatment versus laser monotherapy in NPDR and PDR patients with diabetic macular oedema-Reference-Cited by-同舟云学术

The RELATION study: efficacy and safety of ranibizumab combined with laser photocoagulation treatment versus laser monotherapy in NPDR and PDR patients with diabetic macular oedema

Published:2017-11-01 Issue:3 Volume:96 Page:e377-e385
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:Acta Ophthalmol

Author:

Lang Gabriele E.¹,Liakopoulos Sandra²,Vögeler Jessica³,Weiß Claudia³,Spital Georg⁴,Gamulescu Maria-Andreea⁵,Lohmann Chris⁶,Wiedemann Peter⁷

Affiliation:

1. Department of Ophthalmology; University of Ulm; Ulm Germany

2. Cologne Image Reading Center; Center for Ophthalmology; University of Cologne; Cologne Germany

3. Novartis Pharma GmbH; Nuremberg Germany

4. St. Franziskus Hospital Münster; Münster Germany

5. Department of Ophthalmology; University Hospital Regensburg; Regensburg Germany

6. Department of Ophthalmology; University Teaching Hospital; Munich Germany

7. Department of Ophthalmology; University of Leipzig; Leipzig Germany

Funder

Novartis Pharma

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/aos.13574/fullpdf

Reference23 articles.

1. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up;Arevalo;Ophthalmology,2007

2. Prävalenz der diabetischen Retinopathy, Studie der Versicherten der Deutschen Betriebskrankenkasse 2002-2004;Blum;Ophthalmologe,2007

3. Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab;Bressler;Arch Ophthalmol,2012

4. Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE;Brown;Ophthalmology,2013

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-vascular endothelial growth factor injections vs panretinal photocoagulation laser therapy for proliferative diabetic retinopathy – A systematic review and meta-analysis;Ophthalmology Retina;2024-08

2. Intravitreal conbercept injection with panretinal photocoagulation for high-risk proliferative diabetic retinopathy with vitreous hemorrhage;International Journal of Ophthalmology;2024-06-18

3. Intravitreal anti-vascular endothelial growth factor, laser photocoagulation, or combined therapy for diabetic macular edema: A systematic review and network meta-analysis;Frontiers in Endocrinology;2023-02-02

4. A comparison between the therapeutic effects of Conbercept combined with panretinal photocoagulation and panretinal photocoagulation monotherapy for high-risk proliferative diabetic retinopathy;Frontiers in Endocrinology;2023-01-13

5. A systematic review and meta-analysis of the effect of intravitreal VEGF inhibitors on cardiorenal outcomes;Nephrology Dialysis Transplantation;2022-11-01